Zheng Quan Shi Bao Wang·2025-07-29 08:03Group 1 - The core viewpoint of the article highlights the growing market for liver health products, driven by high customer spending and frequent repurchases, with a projected sales growth of 26% in 2024 for liver health medications [1] - The average annual expenditure for patients on liver health products exceeds 1800 yuan, with an average transaction value of over 260 yuan and a repurchase rate exceeding 50%, indicating a strong consumer commitment [1] - The number of online consultations for liver disease is increasing significantly, with a growth rate of over 67% from Q2 2024 to Q2 2025 [1] Group 2 - Experts emphasize the importance of raising public awareness about liver health and promoting early screening and treatment as key strategies in liver disease prevention [2] - Pharmaceutical companies are committed to increasing R&D investments in liver disease prevention and treatment, with innovative therapies being developed, such as the "dual-antibody therapy" targeting liver fibrosis [2] - Internet medical platforms are seen as crucial in addressing patient pain points by integrating screening, diagnosis, standardized treatment, and management [2] Group 3 - JD Health's sales of antiviral drugs and liver health traditional Chinese medicine have seen over 40% year-on-year growth, particularly in lower-tier markets [3] - JD Health has expanded its home testing services for liver function and hepatitis B screening, now covering 23 cities nationwide, enhancing accessibility for patients [3]